GSK and Pfizer launch joint HIV collaboration

HIV Treat Bull - 2009 Nov/Dec;10(11/12): 26

Following the initial announcement in April 2009 of a collaboration between GlaxoSmithKline and Pfizer’s to create a new specialist company dedicated to HIV, called ViiV Healthcare was launched on 3 November 2009.

GSK holds an 85% interest in ViiV Healthcare and Pfizer holds 15%.

ViiV Healthcare has 10 licensed medicines which generated £1.6 billion in 2008 and a pipeline of seven investigative compounds, including five in phase II development and 10 other potential molecules to develop new HIV treatments.

GSK previous Positive Action programme will be at the core of ViiV Healthcare’s partnership programmes, supporting local communities impacted by HIV/AIDS globally.

The ViiV web site provides an overview of the new company and its current activities, including Positive Action and Community Partnerships, the R&D pipeline, initiatives to improve access, and corporate governance.

Source: Company Press Release: “ViiV Healthcare - a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV”. (3 November 2009).

2009-11-10
IB2009-11-26

©2009. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in November 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.